Last reviewed · How we verify
Durlaza™
At a glance
| Generic name | Durlaza™ |
|---|---|
| Sponsor | New Haven Pharmaceuticals, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Durlaza™ CI brief — competitive landscape report
- Durlaza™ updates RSS · CI watch RSS
- New Haven Pharmaceuticals, Inc. portfolio CI